Jyong Biotech Ltd (MENS) Straddle

Trading a MENS straddle lets you take a pure volatility position on Jyong Biotech Ltd without committing to a direction. Jyong Biotech Ltd's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate MENS straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on MENS profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Jyong Biotech Ltd stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the MENS straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages

Earnings, product cycles, macro prints — any time volatility itself is the trade, the MENS straddle is the cleanest expression of that view. Our scanner prices every MENS straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a MENS straddle into a catalyst or short a MENS straddle to harvest decay, the options straddle setups that matter are all in one place.